KPC PharmaceuticalsInc Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
KPC PharmaceuticalsInc has a total shareholder equity of CN¥5.7B and total debt of CN¥769.1M, which brings its debt-to-equity ratio to 13.5%. Its total assets and total liabilities are CN¥10.0B and CN¥4.3B respectively. KPC PharmaceuticalsInc's EBIT is CN¥500.8M making its interest coverage ratio -1915.5. It has cash and short-term investments of CN¥2.0B.
Anahtar bilgiler
13.5%
Borç/özkaynak oranı
CN¥769.10m
Borç
Faiz karşılama oranı | -1915.5x |
Nakit | CN¥2.01b |
Eşitlik | CN¥5.71b |
Toplam yükümlülükler | CN¥4.31b |
Toplam varlıklar | CN¥10.02b |
Son finansal sağlık güncellemeleri
These 4 Measures Indicate That KPC PharmaceuticalsInc (SHSE:600422) Is Using Debt Safely
Sep 11We Think KPC PharmaceuticalsInc (SHSE:600422) Can Stay On Top Of Its Debt
Jun 04Recent updates
Is KPC Pharmaceuticals,Inc. (SHSE:600422) Trading At A 42% Discount?
Sep 30These 4 Measures Indicate That KPC PharmaceuticalsInc (SHSE:600422) Is Using Debt Safely
Sep 11KPC PharmaceuticalsInc (SHSE:600422) Will Pay A Larger Dividend Than Last Year At CN¥0.20
Jul 25Investors Still Waiting For A Pull Back In KPC Pharmaceuticals,Inc (SHSE:600422)
Jun 25We Think KPC PharmaceuticalsInc (SHSE:600422) Can Stay On Top Of Its Debt
Jun 04KPC PharmaceuticalsInc's (SHSE:600422) Profits May Not Reveal Underlying Issues
Mar 28Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 600422's short term assets (CN¥7.6B) exceed its short term liabilities (CN¥4.0B).
Uzun Vadeli Yükümlülükler: 600422's short term assets (CN¥7.6B) exceed its long term liabilities (CN¥357.2M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 600422 has more cash than its total debt.
Borcun Azaltılması: 600422's debt to equity ratio has reduced from 17.2% to 13.5% over the past 5 years.
Borç Kapsamı: 600422's debt is well covered by operating cash flow (79.2%).
Faiz Kapsamı: 600422 earns more interest than it pays, so coverage of interest payments is not a concern.